These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24632805)

  • 21. Ethical issues at the university-industry interface: a way forward?
    Evans GR; Packham DE
    Sci Eng Ethics; 2003 Jan; 9(1):3-16. PubMed ID: 12645225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Social networks attempt to spark academic-university collaborations.
    Weintraub A
    Nat Biotechnol; 2012 Oct; 30(10):901-3. PubMed ID: 23051789
    [No Abstract]   [Full Text] [Related]  

  • 23. Industry Sponsor Influence in Clinical Trial Reporting in Canada: A Qualitative Interview Study.
    Morrow RL; Mintzes B; Gray G; Law MR; Garrison S; Dormuth CR
    Clin Ther; 2022 Mar; 44(3):374-388. PubMed ID: 34955232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lessons Learned from an Industry, Government and University Collaboration to Restore Stream Habitats and Mitigate Effects.
    Jones NE; Scrimgeour GJ; Tonn WM
    Environ Manage; 2017 Jan; 59(1):1-9. PubMed ID: 27826692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the randomized controlled drug trial in Europe lagging behind the USA?
    Lambers Heerspink HJ; Knol MJ; Tijssen RJ; van Leeuwen TN; Grobbee DE; de Zeeuw D
    Br J Clin Pharmacol; 2008 Dec; 66(6):774-80. PubMed ID: 19032722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Collaborative university-industry R&D practices supporting the pharmaceutical innovation process: Insights from a bibliometric review.
    Ma Z; Augustijn K; de Esch IJP; Bossink B
    Drug Discov Today; 2022 Aug; 27(8):2333-2341. PubMed ID: 35550437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Licensing biotech intellectual property in university-industry partnerships.
    Drozdoff V; Fairbairn D
    Cold Spring Harb Perspect Med; 2015 Jan; 5(3):a021014. PubMed ID: 25605752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Navigating the Murky Waters of Conflict of Interest: Searching for the Middle Path.
    Zonia SC
    J Empir Res Hum Res Ethics; 2016 Feb; 11(1):67-71. PubMed ID: 27106892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expectations and satisfaction of academic investigators in nonclinical collaboration with the pharmaceutical industry.
    Amiri M; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):613-22. PubMed ID: 25720948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Who owns your data? Part III challenges to academic freedom.
    Mills MD
    J Appl Clin Med Phys; 2018 Sep; 19(5):328-329. PubMed ID: 30105777
    [No Abstract]   [Full Text] [Related]  

  • 32. Withholding research results in academic life science. Evidence from a national survey of faculty.
    Blumenthal D; Campbell EG; Anderson MS; Causino N; Louis KS
    JAMA; 1997 Apr; 277(15):1224-8. PubMed ID: 9103347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A foot in two camps: an exploratory study of nurse leaders in universities.
    Ross F; Marks-Maran D; Tye C
    Nurse Educ Today; 2013 Nov; 33(11):1342-6. PubMed ID: 23498842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thoughts of the combination of medicine and engineering and collaborative innovation on surgery in China].
    Lyu ZJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jun; 23(6):562-565. PubMed ID: 32521975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How Do Institutional Conflicts of Interest Between Pharmaceutical Companies and the Healthcare Sector Become Corrupt? A Case Study of Scholarship Donations Between Department of Clinical Anesthesiology, Mie University, and Ono Pharmaceutical in Japan.
    Ozaki A; Murayama A; Harada K; Saito H; Sawano T; Tanimoto T; Ozieranski P
    Front Public Health; 2021; 9():762637. PubMed ID: 35047471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.
    Vilhelmsson A; Davis C; Mulinari S
    PLoS Med; 2016 Jan; 13(1):e1001945. PubMed ID: 26812151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innovation by coercion: Emerging institutionalization of university-industry collaborations in Russia.
    Bychkova O
    Soc Stud Sci; 2016 Aug; 46(4):511-535. PubMed ID: 28948870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Academia-industry symbiosis in organic chemistry.
    Michaudel Q; Ishihara Y; Baran PS
    Acc Chem Res; 2015 Mar; 48(3):712-21. PubMed ID: 25702529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How to set up collaborations between academia and industrial biotech companies.
    Pronk JT; Lee SY; Lievense J; Pierce J; Palsson B; Uhlen M; Nielsen J
    Nat Biotechnol; 2015 Mar; 33(3):237-40. PubMed ID: 25748909
    [No Abstract]   [Full Text] [Related]  

  • 40. Doing science together: Gaining momentum from long-term explorative university-industry research programs.
    Rake B; Sengupta K; Lewin L; Sandström A; McKelvey M
    Drug Discov Today; 2023 Sep; 28(9):103687. PubMed ID: 37356615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.